These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15761926)

  • 1. Biopharmaceutical considerations on antihistamine effects of topically administered emedastine.
    Harada S; Nakada Y; Yamashita F; Hashida M
    J Pharm Sci; 2005 Jan; 94(1):17-24. PubMed ID: 15761926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal administration of emedastine.
    Harada S; Takahashi Y; Nakagawa H
    Biol Pharm Bull; 1993 Sep; 16(9):884-8. PubMed ID: 7903575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vehicle properties on skin penetration of emedastine.
    Harada S; Takahashi Y; Nakagawa H; Yamashita F; Hashida M
    Biol Pharm Bull; 2000 Oct; 23(10):1224-8. PubMed ID: 11041256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical efficacy of emedastine, a potent, selective histamine H1 antagonist for topical ocular use.
    Yanni JM; Stephens DJ; Parnell DW; Spellman JM
    J Ocul Pharmacol; 1994; 10(4):665-75. PubMed ID: 7714410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of in vivo percutaneous absorption of emedastine from bile excretion data using a deconvolution method.
    Harada S; Yamashita F; Hashida M
    Drug Metab Pharmacokinet; 2005 Oct; 20(5):331-6. PubMed ID: 16272750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteers.
    Jansen B; Graselli U; Dallinger S; Kiss B; Wacheck V; Schlagbauer-Wadl H; Assandri A; Müller M
    Eur J Clin Pharmacol; 2000; 55(11-12):837-41. PubMed ID: 10805062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats.
    Shin SC; Choi JS
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):14-9. PubMed ID: 16005195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological profile and clinical efficacy of transdermal patch containing emedastine difumarate (ALLESAGA
    Tanida N; Akiyama K; Terahara T
    Nihon Yakurigaku Zasshi; 2018; 152(5):246-255. PubMed ID: 30393257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro metabolism of an antiallergic agent, emedastine difumarate, in rats and guinea pigs].
    Wada Y; Hamada T; Kawashima T; Awata N
    Yakugaku Zasshi; 1990 Jan; 110(1):40-8. PubMed ID: 1972410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of emedastine eyedrops on acute seasonal allergic conjunctivitis in children].
    Endre L
    Orv Hetil; 2003 Apr; 144(14):665-7. PubMed ID: 12795028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate.
    el-Shazly AE; Masuyama K; Samejima Y; Eura M; Ishikawa T
    Immunopharmacol Immunotoxicol; 1996 Nov; 18(4):587-95. PubMed ID: 8933171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairment.
    Joukhadar C; Herranz U; Pernerstorfer T; Assandri A; Klein N; Schrolnberger C; Lackner E; Eichler HG; Müller M
    Eur J Clin Pharmacol; 2001 Mar; 56(12):905-10. PubMed ID: 11317479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and mass balance study of unlabelled and (14)C-labelled emedastine difumarate in healthy volunteers.
    Brunner M; Kletter K; Assandri A; Ermanno Corrado M; Eichler HG; Müller M
    Xenobiotica; 2002 Sep; 32(9):761-70. PubMed ID: 12396273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihistamine effects of triprolidine from the transdermal administration of the TPX matrix in rats.
    Shin SC; Choi JS
    Arch Pharm Res; 2005 Jan; 28(1):111-4. PubMed ID: 15742818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emedastine difumarate inhibits histamine-induced collagen synthesis in dermal fibroblasts.
    Murota H; Bae S; Hamasaki Y; Maruyama R; Katayama I
    J Investig Allergol Clin Immunol; 2008; 18(4):245-52. PubMed ID: 18714531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of blockade of leukotriene B(4) action in anti-pruritic effects of emedastine in mice.
    Andoh T; Kuraishi Y
    Eur J Pharmacol; 2000 Oct; 406(1):149-52. PubMed ID: 11011046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
    Gutiérrez B; Dordal A; Fort M; Galicia J; Farré AJ
    Methods Find Exp Clin Pharmacol; 1996; 18(6):397-406. PubMed ID: 8892269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selective and sensitive determination of an antiallergic agent, emedastine difumarate (KG-2413), in human plasma by the radioreceptor assay combined with a high-performance liquid chromatography].
    Hamada T; Kawashima T; Awata N
    Yakugaku Zasshi; 1989 Oct; 109(10):749-54. PubMed ID: 2576060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic transport of an antiallergic agent, emedastine difumarate: interspecies difference in rats and guinea pigs.
    Sakai T; Awata N; Watanabe J
    Chem Pharm Bull (Tokyo); 1990 May; 38(5):1349-52. PubMed ID: 2393961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [General review of a non-sedative antihistaminic, astemizole (Hismanal), a H1 receptor antagonist].
    Molkhou P
    Allerg Immunol (Paris); 1988 May; 20(5):197-201. PubMed ID: 2900641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.